Antikor Biopharma

Antikor Biopharma is a company dedicated to developing revolutionary products for the treatment of solid cancers. As a multidisciplinary team from Imperial College London in the UK, the company has over 15 years of pioneering experience in the field of small antibody fragment drug conjugates. It has generated candidate products with optimal pharmacokinetics, pharmacodynamics, and other encouraging preclinical data.